South Africa’s rollout of the groundbreaking HIV prevention injection lenacapavir is off to a strong start in Gauteng.

The provincial Department of Health said more than 6,000 eligible people have received the long-acting HIV prevention treatment since the phased rollout began on 8 June 2026.

READ MORE:

New drug 'lenacapavir' 100% effective in preventing HIV infections

Misinformation threatens rollout of HIV prevention drug lenacapavir

Health Dept welcomes arrival of new HIV prevention medicine Lenacapavir

This is 131% of the province's initial monthly target of just under 4,700 initiations.

Lenacapavir is aimed at HIV-negative people who are at substantial risk of contracting the virus and forms part of South Africa's efforts to end AIDS as a public health threat by 2030.

Gauteng Department of Health’s spokesperson, Steve Mabona, explained.

“The department has noted a strong uptake of lenacapavir in all five districts. Tshwane recorded the highest number of initiations, sitting at 2,216, followed by Johannesburg at 1981, Ekurhuleni 1435, Sedibeng 377, West Rand 121 initiations.

“The department continues to maintain adequate stock levels to support this programme.”